Completed Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma NCT01002755 Conditions Agammaglobulinemia, Blood Platelet Disorders, Blood Protein Disorders, +33 more Locations M D Anderson Cancer Center — Houston, Texas, United States View Trial Details
